CorMedix, Inc. (CRMD)
CorMedix Market Cap : 517.78M for March 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Pfizer Inc. | 151.37B |
| Amicus Therapeutics, Inc. | 4.512B |
| ANI Pharmaceuticals, Inc. | 1.618B |
| Castle Biosciences, Inc. | 767.06M |
| Indivior Pharmaceuticals, Inc. | 3.870B |
Market Cap Related Metrics
| PE Ratio | 3.302 |
| PS Ratio | 1.686 |
| Price to Book Value | 1.278 |
| Price to Free Cash Flow | 3.042 |
| Price | 6.55 |
| Earnings Yield | 30.28% |
| Operating PE Ratio | 3.501 |
| Normalized PE Ratio | 3.289 |